Fred R Hirsch

Fred R Hirsch

UNVERIFIED PROFILE

Are you Fred R Hirsch?   Register this Author

Register author
Fred R Hirsch

Fred R Hirsch

Publications by authors named "Fred R Hirsch"

Are you Fred R Hirsch?   Register this Author

100Publications

3314Reads

24Profile Views

Galectin-9 in non-small cell lung cancer.

Lung Cancer 2019 Oct 16;136:80-85. Epub 2019 Aug 16.

Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University Medical School Cancer Institute, Tongji University School of Medicine, No. 507 Zhengmin Road, Shanghai, 200433, People's Republic of China. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2019.08.014DOI Listing
October 2019

OX40 and OX40L protein expression of tumor infiltrating lymphocytes in non-small cell lung cancer and its role in clinical outcome and relationships with other immune biomarkers.

Transl Lung Cancer Res 2019 Aug;8(4):352-366

Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University Medical School Cancer Institute, Tongji University School of Medicine, Shanghai 200433, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/tlcr.2019.08.15DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6749115PMC
August 2019

Concomitant EGFR Mutation and EML4-ALK Rearrangement in Lung Adenocarcinoma Is More Frequent in Multifocal Lesions.

Clin Lung Cancer 2019 Jul 25;20(4):e517-e530. Epub 2019 Apr 25.

Clinical Institute for Lung Cancer, Mount Sinai Cancer, Mount Sinai Health System, Icahn School of Medicine at Mount Sinai, New York, NY. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2019.04.008DOI Listing
July 2019

c-MET as a biomarker in patients with surgically resected non-small cell lung cancer.

Lung Cancer 2019 Jul 1;133:69-74. Epub 2019 May 1.

Thoracic Oncology Center, Theme Cancer, Karolinska University Hospital/Department of Oncology- Pathology, Karolinska Institutet, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2019.04.028DOI Listing
July 2019

Low-Dose Apatinib Optimizes Tumor Microenvironment and Potentiates Antitumor Effect of PD-1/PD-L1 Blockade in Lung Cancer.

Cancer Immunol Res 2019 Apr 12;7(4):630-643. Epub 2019 Feb 12.

Department of Medicine, Division of Medical Oncology and Department of Pathology, University of Colorado Cancer Center, Aurora, Colorado.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2326-6066.CIR-17-0640DOI Listing
April 2019

Risk factors for nicotine dependence in Chinese patients with lung cancer.

J Int Med Res 2019 Jan 10;47(1):391-397. Epub 2018 Oct 10.

3 Division of Medical Oncology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0300060518802738DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6384457PMC
January 2019

Physician Bias in Prophylactic Cranial Irradiation Decision Making-An Opportunity for a Patient Decision Aid.

Clin Lung Cancer 2018 11 17;19(6):476-483. Epub 2018 Feb 17.

Department of Radiation Oncology, University of Colorado School of Medicine, Aurora, CO. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2018.02.005DOI Listing
November 2018

TIM-3, a promising target for cancer immunotherapy.

Onco Targets Ther 2018 16;11:7005-7009. Epub 2018 Oct 16.

Division of Medical Oncology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.

View Article

Download full-text PDF

Source
https://www.dovepress.com/tim-3-a-promising-target-for-cance
Publisher Site
http://dx.doi.org/10.2147/OTT.S170385DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6198883PMC
October 2018

Scientific Advances and New Frontiers in Mesothelioma Therapeutics.

J Thorac Oncol 2018 09;13(9):1269-1283

Thoracic and Gastrointestinal Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2018.06.011DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6643278PMC
September 2018

A miRNA Panel Predicts Sensitivity of FGFR Inhibitor in Lung Cancer Cell Lines.

Clin Lung Cancer 2018 09 28;19(5):450-456. Epub 2018 Jun 28.

Department of Medicine, Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, CO. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2018.06.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6339511PMC
September 2018

sLAG-3 in non-small-cell lung cancer patients' serum.

Onco Targets Ther 2018 13;11:4781-4784. Epub 2018 Aug 13.

Division of Medical Oncology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/OTT.S164178DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6097502PMC
August 2018

Serum microRNAs improving the diagnostic accuracy in lung cancer presenting with pulmonary nodules.

J Thorac Dis 2018 Aug;10(8):5080-5085

Division of Medical Oncology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.

View Article

Download full-text PDF

Source
http://jtd.amegroups.com/article/view/23629/17841
Publisher Site
http://dx.doi.org/10.21037/jtd.2018.07.138DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6129919PMC
August 2018

Increased EGFR Phosphorylation Correlates with Higher Programmed Death Ligand-1 Expression: Analysis of TKI-Resistant Lung Cancer Cell Lines.

Biomed Res Int 2017 8;2017:7694202. Epub 2017 Oct 8.

Division of Medical Oncology, University of Colorado Anschutz Medical Campus, 12801 E. 17th Ave. RC-1 South, Rm 8402J, Aurora, CO 80045, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2017/7694202DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5651099PMC
July 2018

Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology.

Arch Pathol Lab Med 2018 Mar 22;142(3):321-346. Epub 2018 Jan 22.

From the Departments of Pathology (Drs Lindeman and Sholl) and Medicine (Dr Kwiatkowski), Brigham and Women's Hospital, Boston, Massachusetts; the Cancer Center (Dr Bernicker) and the Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas (Dr Cagle); the Department of Pathology, University of Colorado School of Medicine, Denver (Dr Aisner); the Diagnostic and Molecular Pathology Laboratory (Dr Arcila) and the Molecular Diagnostics Service (Dr Ladanyi), Memorial Sloan Kettering Cancer Center, New York, New York; the Department of Pathology & Medicine, Pulmonary, Critical Care and Sleep Medicine, New York, New York (Dr Beasley); the Pathology and Laboratory Quality Center, College of American Pathologists, Northfield, Illinois (Mss Colasacco and Ventura); the Department of Pathology, University of Pittsburgh, Pittsburgh, Pennsylvania (Dr Dacic); the Department of Medicine and Pathology, University of Colorado, Denver (Dr Hirsch); the Department of Pathology, University of Aberdeen, Aberdeen, Scotland (Dr Kerr); the Department of Molecular Pathology, Roswell Park Cancer Institute, Buffalo, New York (Dr Nowak); the Clinical and Scientific Affairs Division, Association for Molecular Pathology, Bethesda, Maryland (Dr Temple-Smolkin); the Molecular Therapeutics and Biomarkers Laboratory, Peter Maccallum Cancer Center, Melbourne, Australia (Dr Solomon); the Department of Pathology, VU University Medical Center, Amsterdam, the Netherlands (Dr Thunnissen); the Department of Laboratory Medicine and Pathobiology, Princess Margaret Cancer Center, Toronto, Ontario, Canada (Dr Tsao); Scientific Affairs, International Association for the Study of Lung Cancer, Aurora, Colorado (Dr Wynes); and the Department of Pathology and Molecular Diagnostics, Aichi Cancer Center, Nagoya, Japan (Dr Yatabe). Dr Souter is in private practice in Wellanport, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5858/arpa.2017-0388-CPDOI Listing
March 2018

Genomic Testing in Lung Cancer: Past, Present, and Future.

J Natl Compr Canc Netw 2018 03;16(3):323-334

From Assistance Publique Hôpitaux de Marseille, Mutidisicplinary Oncology and Therapeutic Innovations Department, Marseille, France; Centre de Recherche en Cancérologie de Marseille (Cancer Research Center of Marseille), Inserm UMR1068, CNRS UMR7258, and Aix-Marseille University UM105, Marseille France; Department of Pathology, University Health Network and Princess Margaret Cancer Centre and University of Toronto, Toronto, Ontario, Canada; and University of Colorado Cancer Center, Denver, Colorado.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2017.7019DOI Listing
March 2018

EGFR Gene Copy Number by FISH May Predict Outcome of Necitumumab in Squamous Lung Carcinomas: Analysis from the SQUIRE Study.

J Thorac Oncol 2018 02 20;13(2):228-236. Epub 2017 Nov 20.

Division of Medical Oncology, Department of Medicine, Anschutz Medical Campus, University of Colorado, Aurora, Colorado. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2017.11.109DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6233716PMC
February 2018

PACIFIC trial: new perspectives for immunotherapy in lung cancer.

Transl Lung Cancer Res 2018 Feb;7(Suppl 1):S19-S24

Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/tlcr.2017.12.12DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5835637PMC
February 2018

Biomarker Testing for Personalized Therapy in Lung Cancer in Low- and Middle-Income Countries.

Am Soc Clin Oncol Educ Book 2017 ;37:403-408

From the University of Colorado School of Medicine, University of Colorado Cancer Center, International Association for the Study of Lung Cancer, Aurora, CO; Institute for Pulmonary Diseases of Vojvodina, University of Novi Sad, Sremska Kamenica, Serbia; National Cancer Institute, Cairo University, Giza, Egypt; Chiang Mai University, Chiang Mai, Thailand; Pathology Department, Chiang Mai University, Chiang Mai, Thailand; Hospital Italiano Buenos Aires, Perón, Argentina; University of Colorado Anschutz Medical Campus, Aurora, CO.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/EDBK_175243DOI Listing
December 2017

Potential future consideration for imaging and blood-based biomarkers for precision medicine in lung cancer.

Transl Lung Cancer Res 2017 Dec;6(6):713-715

Department of Radiation Oncology, Case Western University Hospital, Cleveland, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/tlcr.2017.09.11DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5709135PMC
December 2017

Seven-microRNA panel for lung adenocarcinoma early diagnosis in patients presenting with ground-glass nodules.

Onco Targets Ther 2017 13;10:5915-5926. Epub 2017 Dec 13.

Division of Medical Oncology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/OTT.S151432DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5732566PMC
December 2017

Access to Cancer Specialist Care and Treatment in Patients With Advanced Stage Lung Cancer.

Clin Lung Cancer 2017 11 26;18(6):640-650.e2. Epub 2017 Apr 26.

Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2017.04.010DOI Listing
November 2017

MHC class II expression in lung cancer.

Lung Cancer 2017 10 29;112:75-80. Epub 2017 Jul 29.

Division of Medical Oncology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, 80045, CO, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2017.07.030DOI Listing
October 2017

Early detection of lung cancer by using an autoantibody panel in Chinese population.

Oncoimmunology 2018 16;7(2):e1384108. Epub 2017 Oct 16.

Department of Medicine, Division of Medical Oncology, University of Colorado Cancer Center, Anschutz Medical Campus, Aurora, CO, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/2162402X.2017.1384108DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5749655PMC
October 2017

Comprehensive Analysis of EGFR-Mutant Abundance and Its Effect on Efficacy of EGFR TKIs in Advanced NSCLC with EGFR Mutations.

J Thorac Oncol 2017 09 15;12(9):1388-1397. Epub 2017 Jun 15.

Departments of Medicine and Pathology, University of Colorado Cancer Center, Aurora, Colorado.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2017.06.006DOI Listing
September 2017

Overcoming resistance to EGFR tyrosine kinase inhibitors in lung cancer, focusing on non-T790M mechanisms.

Expert Rev Anticancer Ther 2017 09 17;17(9):779-786. Epub 2017 Jul 17.

a Division of Medical Oncology , University of Colorado Anschutz Medical Campus , Aurora , CO , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14737140.2017.1355243DOI Listing
September 2017

Potential effect of spliceosome inhibition in small cell lung cancer irrespective of the MYC status.

PLoS One 2017 13;12(2):e0172209. Epub 2017 Feb 13.

Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0172209PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5305228PMC
August 2017

Therapy-induced E-cadherin downregulation alters expression of programmed death ligand-1 in lung cancer cells.

Lung Cancer 2017 07 19;109:1-8. Epub 2017 Apr 19.

Division of Medical Oncology, University of Colorado Anschutz Medical Campus, 12801 E. 17th Ave, RC-1 South, Aurora, CO 80045, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2017.04.010DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6174882PMC
July 2017

Heterogeneity in Immune Marker Expression after Acquisition of Resistance to EGFR Kinase Inhibitors: Analysis of a Case with Small Cell Lung Cancer Transformation.

J Thorac Oncol 2017 06 11;12(6):1015-1020. Epub 2017 Feb 11.

Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, Colorado. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2017.02.002DOI Listing
June 2017

Programmed death ligand 1 testing: is there one best test?

Authors:
Fred R Hirsch

Clin Adv Hematol Oncol 2017 Jun;15(6):438-440

University of Colorado Denver School of Medicine, Denver, Colorado.

View Article

Download full-text PDF

Source
June 2017

LAG-3 Protein Expression in Non-Small Cell Lung Cancer and Its Relationship with PD-1/PD-L1 and Tumor-Infiltrating Lymphocytes.

J Thorac Oncol 2017 05 26;12(5):814-823. Epub 2017 Jan 26.

Division of Medical Oncology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2017.01.019DOI Listing
May 2017

PD-1, PD-L1 Protein Expression in Non-Small Cell Lung Cancer and Their Relationship with Tumor-Infiltrating Lymphocytes.

Med Sci Monit 2017 Mar 9;23:1208-1216. Epub 2017 Mar 9.

Division of Medical Oncology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356616PMC
http://dx.doi.org/10.12659/msm.899909DOI Listing
March 2017

Challenges in Facing the Lung Cancer Epidemic and Treating Advanced Disease in Latin America.

Clin Lung Cancer 2017 01 5;18(1):e71-e79. Epub 2016 Jun 5.

International Association for the Study of Lung Cancer and University of Colorado, Denver, Colorado.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2016.05.003DOI Listing
January 2017

Lung cancer: current therapies and new targeted treatments.

Lancet 2017 01 27;389(10066):299-311. Epub 2016 Aug 27.

Medical Oncology Department, Hospital Universitario Doce de Octubre and CNIO, Madrid, Spain.

View Article

Download full-text PDF

Source
http://www.thelancet.com/pdfs/journals/lancet/PIIS0140-6736(
Web Search
http://dx.doi.org/10.1016/S0140-6736(16)30958-8DOI Listing
January 2017

Primary Double-Strike Therapy for Cancers to Overcome EGFR Kinase Inhibitor Resistance: Proposal from the Bench.

J Thorac Oncol 2017 01 15;12(1):27-35. Epub 2016 Sep 15.

Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, Colorado. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2016.09.003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5327855PMC
January 2017

PIK3CA mutations as prognostic factor in squamous cell lung carcinoma.

Lung Cancer 2017 01 28;103:52-57. Epub 2016 Nov 28.

Dept of Cancer Research, Oslo University Hospital-The Norwegian Radium Hospital, Oslo, Norway; Dept of Oncology, Oslo University Hospital-The Norwegian Radium Hospital, Oslo, Norway. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2016.11.018DOI Listing
January 2017

cMET Exon 14 Skipping: From the Structure to the Clinic.

J Thorac Oncol 2016 09 17;11(9):1423-32. Epub 2016 May 17.

Center for Oncological Research, University of Antwerp, Wilrijk, Antwerp, Belgium; Phase I Early Clinical Trials Unit, Oncology Department, Antwerp University Hospital, Antwerp, Belgium. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2016.05.005DOI Listing
September 2016

Lymphocyte-activation gene-3, an important immune checkpoint in cancer.

Cancer Sci 2016 Sep 25;107(9):1193-7. Epub 2016 Aug 25.

Division of Medical Oncology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/cas.12986DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5021038PMC
September 2016

New and emerging targeted treatments in advanced non-small-cell lung cancer.

Lancet 2016 Sep 1;388(10048):1012-24. Epub 2016 Sep 1.

Department of Medicine, Division of Medical Oncology and Department of Pathology, University of Colorado Cancer Center, Aurora, CO, USA.

View Article

Download full-text PDF

Source
http://www.thelancet.com/pdfs/journals/lancet/PIIS0140-6736(
Web Search
http://linkinghub.elsevier.com/retrieve/pii/S014067361631473
Publisher Site
http://dx.doi.org/10.1016/S0140-6736(16)31473-8DOI Listing
September 2016

Clinical potential of necitumumab in non-small cell lung carcinoma.

Onco Targets Ther 2016 31;9:5427-37. Epub 2016 Aug 31.

Division of Medical Oncology, Department of Medicine, University of Colorado Cancer Center, Aurora, CO, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/OTT.S114039DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5012835PMC
September 2016

PD-L1 Expression in Lung Cancer.

J Thorac Oncol 2016 07 23;11(7):964-75. Epub 2016 Apr 23.

Department of Medicine/Medical Oncology, University of Colorado Cancer Center, University of Colorado, Denver, Colorado; Department of Pathology, University of Colorado, Denver, Colorado. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2016.04.014DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5353357PMC
July 2016

Correction: "From Mice to Men and Back: An Assessment of Preclinical Model Systems for the Study of Lung Cancers".

J Thorac Oncol 2016 07;11(7):e88-9

Hamon Center for Therapeutic Oncology Research, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas; Departments of Medicine and Pharmacology, University of Texas Southwestern Medical Center, Dallas, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2016.04.003DOI Listing
July 2016

Heterogeneity in Tumors and Resistance to EGFR TKI Therapy-Letter.

Cancer Res 2016 05 2;76(10):3109-10. Epub 2016 May 2.

Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, Colorado.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-15-2916DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5353479PMC
May 2016

Durable brain response with pulse-dose crizotinib and ceritinib in ALK-positive non-small cell lung cancer compared with brain radiotherapy.

J Clin Neurosci 2016 Apr 8;26:46-9. Epub 2015 Dec 8.

Thoracic Cancer Unit, Davidoff Cancer Center, Rabin Medical Center, Kaplan Street, Petah Tikva 49100, Israel; Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jocn.2015.05.068DOI Listing
April 2016

Programmed Death Ligand-1 Immunohistochemistry: Friend or Foe?

Arch Pathol Lab Med 2016 Apr 12;140(4):326-31. Epub 2016 Jan 12.

From the Department of Pathology, Aberdeen University School of Medicine, Aberdeen Royal Infirmary, Aberdeen, Scotland, United Kingdom (Dr Kerr); and.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5858/arpa.2015-0522-SADOI Listing
April 2016

Postprogression Prolongation of Survival in EGFR-Mutated Lung Cancer: Reconciling the ASPIRATION and IMPRESS Trials.

JAMA Oncol 2016 Mar;2(3):300-1

University of Colorado Cancer Center, Aurora.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2015.4920DOI Listing
March 2016

From Mice to Men and Back: An Assessment of Preclinical Model Systems for the Study of Lung Cancers.

J Thorac Oncol 2016 Mar 24;11(3):287-99. Epub 2015 Dec 24.

Hamon Center for Therapeutic Oncology Research, Simmons Comprehensive Cancer Center and Departments of Medicine and Pharmacology, University of Texas Southwestern Medical Center, Dallas, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2015.10.009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4809191PMC
March 2016

Hepatic Metastases is Associated with Poor Efficacy of Erlotinib as 2nd/3rd Line Therapy in Patients with Lung Adenocarcinoma.

Med Sci Monit 2016 Jan 26;22:276-83. Epub 2016 Jan 26.

Division of Medical Oncology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4734673PMC
http://dx.doi.org/10.12659/msm.896607DOI Listing
January 2016